BIOTIME, INC. - 8-K

Company

Lineage Cell Therapeutics, Inc.

Filed

November 3, 2010

Period of Report

November 2, 2010

Accession Number

0001157523-10-006483

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →